Finance

Lists
Why is NEUP down 4.80%?
Dive Deeper
NEUP:NASDAQ
Neuphoria Therapeutics Inc
$2.58
-4.80%
(-0.13) 1D
Nov 12, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEUP...
Open
$2.67
High
$2.76
Low
$2.54
Mkt. cap
13.96M
Avg. vol.
30.06K
Volume
0.00
52-wk high
$5.53
52-wk low
$2.54
EPS
-$3.06
Shares outstanding
5.41M
No. of employees
1
Open
$2.67
High
$2.76
Low
$2.54
Mkt. cap
13.96M
Avg. vol.
30.06K
Volume
0.00
52-wk high
$5.53
52-wk low
$2.54
EPS
-$3.06
Shares outstanding
5.41M
No. of employees
1
News stories
From web sources and news partners
About Neuphoria Therapeutics Inc
CEO-
Employees1
Founded1996
HeadquartersMillis, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteneuphoriatx.com
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Hold
Maintained
-
-
07/27/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$20.00
+675.2%
10/30/2025
Elemer Piros
Lucid Capital
Hold
Downgraded
$2.30
-10.9%
10/21/2025
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
1.17M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.79M
190.02K
-860.12K
-371.03K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.87M
2.16M
1.69M
1.73M
Operating expense
5.65M
2.35M
827.28K
1.36M
Total operating expenses
5.65M
2.35M
827.28K
1.36M
Operating income
-5.65M
-2.35M
-827.28K
-183.92K
Other non operating income
-4.37M
5.38M
435.19K
-1.45M
EBT including unusual items
-9.94M
1.83M
-539.86K
-4.94M
EBT excluding unusual items
-9.94M
3.07M
-497.44K
-1.51M
Income tax expense
-34.79K
-34.79K
-34.79K
-34.79K
Effective tax rate
0.35%
-1.90%
6.44%
0.70%
Other operating expenses
-
-
-
-
Net income
-9.91M
1.86M
-505.06K
-4.90M
Net profit margin
-
-
-
-417.70%
Earnings per share
-4.41
0.41
-0.09
0.26
Interest and investment income
142.00K
167.31K
186.17K
170.09K
Interest expense
-
-
-
-
Net interest expenses
142.00K
167.31K
186.17K
170.09K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.49M
-2.18M
-661.59K
-18.24K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps